We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Dual-Function Wound Patch Combines Infection Sensing and Treatment

By LabMedica International staff writers
Posted on 24 Mar 2026

Chronic wounds require continuous, adaptive care and place a heavy burden on health systems. More...

Clinicians need dressings that can detect early infection while providing therapy without frequent changes. Existing “smart” dressings typically monitor or medicate, but integrating both functions in one device has been challenging. Researchers have now developed a dual‑function wound patch that aims to simplify monitoring and treatment in a single, scalable platform.

Researchers at RMIT University (Melbourne, Australia) have created a hydrogel‑based smart wound dressing that embeds carbon dots, which are biocompatible carbon nanoparticles, directly into the material. The platform is designed to sense the wound state and deliver therapy using the same integrated system. The approach seeks to reduce design complexity compared with devices that rely on separate, expensive sensing components.

The dressing leverages carbon dots to image and sense changes in the wound microenvironment while acting as therapeutic artificial enzymes, or nanozymes, to counter inflammation. It changes color in response to pH shifts associated with infection, enabling readout with portable smart devices. When infection‑related signals are detected, the hydrogel automatically releases therapeutic nanozymes, and clinicians or patients can also trigger release manually by applying gentle pressure to the patch.

Initial studies were conducted at lab scale, with validation in appropriate in vivo wound models identified as a key next step. The team is seeking industry partnerships to refine the design and scale manufacturing for clinical translation. According to the researchers, the patch’s dual function could support more timely and effective intervention by enabling responsive detection and treatment in one dressing.

The work drew on RMIT’s Micro Nano Research Facility and its Microscopy and Microanalysis Facility. The study, titled “Carbon-dot nanozyme-empowered responsive hydrogels for smart wound dressing,” was published in Chemical Engineering Science. The researchers report that the streamlined design is intended to address barriers that have limited commercialization of smart wound dressings.

“Many smart wound dressings developed in research laboratories are difficult to translate into real clinical products because they rely on complex designs or expensive sensing systems,” said Dr Haiyan Li, Senior Lecturer at RMIT’s School of Engineering.  “Our approach integrates sensing and dual-mode therapeutic functions into a single dressing with a simple, streamlined design, which helps address some of the key challenges that have previously limited commercial translation.” 

“Ultimately, our goal is to translate this research into practical smart wound dressings and integrate this smart platform into a digital health ecosystem, where the data from the patch is collected, analysed, and used to drive clinical decisions to advance chronic wound management,” said Dr Lei Bao, Senior Lecturer at RMIT’s School of Engineering.

Related Links
RMIT University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

Alzheimer’s disease is the most common cause of dementia, accounting for an estimated 60–70% of cases worldwide. Its progressive effects on memory, thinking, behavior, and daily functioning underscore... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.